MyLife Diabetes Care announced that its transition into an independent company has now been formally completed.

LifeScan CEO Valerie Asbury said on social media today that she is retiring from the glucose management technology developer.

The site, in Lehigh Valley, will serve as the company’s newest injectable medicine and device manufacturing facility. Indianapolis-based Lilly plans to produce next-generation weight-loss therapies ...

Senseonics (NYSE:SENS) announced today that its Eversense 365 continuous glucose monitor (CGM) system received CE mark ...

Insulin patch pump maker ViCentra announced today that it appointed Reman McDonagh as its VP, global marketing.

Glucotrack (Nasdaq:GCTK) announced today that it received new U.S. patents for its continuous blood glucose monitoring (CBGM) ...

CraniUS Therapeutics announced today that it raised $20 million in a Series B financing round to accelerate the development ...

Glaukos (NYSE:GKOS) announced today that the FDA approved a new drug application (NDA) labeling supplement for its iDose TR ...

MannKind (Nasdaq:MNKD) announced today that it received FDA approval, updating the prescribing information for Afrezza ...

BD and Ypsomed will expand their collaboration through the development of a 5.5 ml version of BD’s Neopak XtraFlow glass ...

[Image taken by Sean Whooley at the American Diabetes Association’s 85th Scientific Sessions in Chicago.] The biggest names in diabetes tech gathered in Chicago this past weekend for the American ...

Embecta (Nasdaq:EMBC) CEO Dev Kurdikar says the company set out for its second full year since spinning off from BD with three clear goals. The company wanted to keep the core business strong, ...